Omada Health is announcing a new funding with the California Health Care Foundation (CHCF) and The Kresge Foundation to extend the reach of Prevent, its online program for people with prediabetes, to low income populations throughout the US. The company will use the new money to conduct Prevent pilots in select low income clinics, and increase access amongst Medicaid plans nationwide. Moreover, this effort will also include development of a Spanish-language adaptation of Prevent.
“These investments from CHCF and The Kresge Foundation are a tremendous validation of digital therapeutics as a high-potential new category of medical intervention,” said Sean Duffy, CEO of Omada Health. “Through strategic relationships like these, we can more rapidly accomplish Omada Health’s mission of bringing the world’s most effective behavior change therapies to every patient that can benefit from them.”
Omada’s Prevent program is credited for helping patients lose weight and make the sort of lifestyle changes shown to help reduce the risk of type 2 diabetes.CHCF is making a $450,000 program-related investment in Omada Health through the CHCF Health Innovation Fund. The Kresge Foundation also invested $500,000 through its Social Investment Practice. The two parties will also fund and publish an independent evaluation of the efficacy of Prevent in low-income populations based on data collected during the pilot.
Prevent is an online diabetes prevention program (DPP) based on guidelines published by the National Diabetes Prevention Program (NDPP), a public-private initiative led by the Centers for Disease Control & Prevention (CDC). The program, which has already been adopted by a variety of employers and health plans, is credited for helping patients lose weight and make the sort of lifestyle changes shown to help reduce the risk of type 2 diabetes. It is guided by dedicated health coaches and offers community social support, meaning every participant has real people, in real-time, monitoring their progress and offering 24/7 feedback.
Omada Health is committed to pay-for-performance models for digital therapeutics, and the cost of Prevent is outcomes-based with program costs directly tied to patient success.